12:00 AM
 | 
Jun 03, 2002
 |  BioCentury  |  Strategy

Stem cell window in Japan

Sosei Co. Ltd. is focused on development of therapeutics via in-licensing and its internal drug re-profiling technology. But the company also sees a special window of opportunity for stem cells in Japan. Thus, the company is pursuing a joint venture model - forming Stem Cell Sciences KK with Stem Cell Sciences Ltd. Sosei believes this structure will keep its resources allocated to products, while preserving the...

Read the full 309 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >